Management of Stage 4 Chronic Kidney Disease

Nephrology Referral and Diagnostic Workup

The Canadian Society of Nephrology guidelines recommend referral to a nephrology specialist for patients with an eGFR <30 mL/min/1.73 m², as this meets absolute criteria for specialist consultation, to determine etiology, assess progression risk, and establish a management plan 1
Evaluate for reversible causes of kidney dysfunction, including reviewing medications, assessing hydration status, and checking for urinary obstruction, as these factors can impact kidney function 2
In elderly females with reduced muscle mass, serum creatinine may underestimate the severity of renal dysfunction, highlighting the importance of considering muscle mass in renal function assessment 3, 4

The American College of Cardiology recommends targeting blood pressure <140/90 mm Hg to reduce CKD progression, and using ACE inhibitors or ARBs if albuminuria is present (ACR ≥300 mg/g or ≥30 mg/mmol) 1
The Canadian Society of Nephrology guidelines suggest initiating statin therapy for cardiovascular risk reduction, as cardiovascular disease is the leading cause of morbidity and mortality in CKD 1
Managing associated comorbidities aggressively, particularly cardiovascular disease, is crucial in patients with CKD 1

Review all medications and adjust doses based on eGFR 28 mL/min/1.73 m², as drug accumulation from reduced renal excretion is a significant cause of adverse drug reactions in elderly patients with CKD 5
Many renally-cleared drugs require significant dose reduction at this level of kidney function, emphasizing the need for careful medication management 6, 7, 8
Be cautious with medications that affect renal hemodynamics, such as NSAIDs, which can precipitate acute kidney injury 5

At eGFR 28 (Stage G4), monitoring should be every 3 months for eGFR and albuminuria, with more frequent monitoring if evidence of rapid progression 9
The interdisciplinary approach is most beneficial for patients with eGFR <30 mL/min/1.73 m², highlighting the importance of collaborative care in CKD management 1
Calculate annual eGFR decline from serial measurements to assess progression risk, and consider using the Kidney Failure Risk Equation (KFRE) to predict risk of progression to kidney failure 9

Elderly patients have reduced muscle mass, so "normal" creatinine levels may mask significant renal impairment, emphasizing the need for careful assessment of renal function in this population 3, 4
Pharmacokinetics are altered in elderly patients, with reduced hepatic metabolism, decreased renal clearance, and altered volume of distribution, highlighting the need for careful medication management 5
Use the CKD-EPI equation for the most accurate eGFR estimation in elderly patients, as it takes into account muscle mass and other factors that affect renal function 5